Assessment of vaccine efficacy by neutralizing antibodies_YHLO

YHLO

YHLO

Language

Reproductive Health

Home page

2024/06/05

Cell Discovery-Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine

2024/06/05

Lancet Infectious Diseases-Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNA

< 1 >

YHLO

Home
Products
- CLIA
  - Analyzers
  - Reagents
- Chemistry
- TLA
- LIA
- ESR
Pubilcations
- Autoimmunity
- Reproductive Health
- Diabetes
- Liver Disease
- Infection
- COVID-19
- ESR
- Others
News
- YHLO News
About YHLO
Contact us
- Career
- Service

Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Tel: +86 755 26601910

Email: marketing@szyhlo.com

youtube

instagram

wechat

wechat

Copyright© 2024 Shenzhen YHLO Biotech Co., Ltd.

Powered by 300.cn | SEO | Business License

8

Email

marketing@szyhlo.com

9

Tel

+86 755 26601910